Navigation Links
STALLERGENES: Immunotherapy Tablet Containing Recombinant Allergen (rBet v 1) of Birch Pollen: Positive Results for a Phase IIb/III Trial
Date:9/16/2009

rapy products.

    Euronext Paris (Compartment B)
    SBF 120.
    ISIN code: FR0000065674
    Reuters code: GEN.PA
    Bloomberg code: GEN.FP


    Additional information is available athttp://www.stallergenes.com
    ---------------------------------

[1] Bousquet J. et al. Geographical variation in the prevalence of positive skin prick tests to environmental aeroallergens in the European Community Respiratory Health Survey I. Allergy 2007: 62: 301-309.


'/>"/>
SOURCE Stallergenes
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. STALLERGENES: 1st Half-Year 2009: Performance Ahead of Expectations
2. STALLERGENES: Strong Sales Growth in 1st Half-Year: up 12% Full-Year Guidance Maintained
3. STALLERGENES: 2008: Strong Performance
4. Stallergenes: 2008: Sales Up 16% - Excellent Performance - Guidance Exceeded
5. Stallergenes: Launch of a Phase III Clinical Trial in Adults for Oralair(R) Grasses in the United States Operating Income Expected to Remain Stable in 2009
6. Stallergenes: Sales at end September 2008: + 17% - 2008 Sales Guidance Revised Upwards: + 14%
7. Stallergenes: First Half Year 2008: A 19% Increase in Operating Profit and Net Profit
8. Stallergenes: Q2 2008 Sales up 18% Revision Upwards of 2008 Sales Growth
9. STALLERGENES: 2007: A Further Year of Strong Growth: Up 16%
10. STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study
11. Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
(Date:5/20/2015)... MECHANICSBURG, Pa. , May 20, 2015 /PRNewswire/ ... announced that the Federal Trade Commission granted early ... (HSR) Antitrust Improvements Act of 1976, as amended, ... by MJ Acquisition Corporation, a joint venture that ... XII, L.P. As previously announced, MJ ...
(Date:5/20/2015)... 20, 2015  Haemonetics Corporation (NYSE: HAE ) ... CEO, will present at The Jefferies 2015 Global Healthcare ... June 1 st , 2015 at 8:30am Eastern time.  ... presentation live via webcast at: http://wsw.com/webcast/jeff88/hae ... HAE ) is a global healthcare company dedicated to ...
(Date:5/20/2015)... MA (PRWEB) May 20, 2015 ... transporter assay services for Drug-Drug Interactions (DDI), Metabolism ... Pharma, a world leader in assessing impact of ... Systems Pharmacology supported by biosimulation, announced today that ... agreement allows both companies to expand their product ...
Breaking Biology Technology:Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 2Optivia Biotechnology Inc. and Rhenovia Pharma Sign Partnership Agreement 3
... Forest Service Forest Products Laboratory (FPL) have joined with ... in an effort to reduce the economic costs and ... and government offices while simultaneously improving the ... 500,000 tons of bleached kraft paper, which includes the ...
... -- Astronomers from the University of Wisconsin-Madison and ... Thursday will release the first astronomical images obtained by ... telescope now equivalent to the largest optical telescope in ... the consortium that built the telescope on a remote ...
... without saying: Life often doesn't turn out as planned. ... manager in the pharmaceutical industry, really did intend to ... fulfilling career. After nearly 30 years of experience in ... and small in Connecticut, Colorado and California, Van Campen ...
Cached Biology Technology:Reducing brightness to make a better paper 2Reducing brightness to make a better paper 3Van Campen reviving UW's drug-development related education 2Van Campen reviving UW's drug-development related education 3Van Campen reviving UW's drug-development related education 4Van Campen reviving UW's drug-development related education 5Van Campen reviving UW's drug-development related education 6
(Date:5/5/2015)... May 5, 2015, NXT-ID, Inc. (NASDAQ: NXTD ... on the growing mobile commerce market, reminds investors and media ... Officer, is presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held ... The three-day conference is organized into a ... in is themed Global Fraud: Where is the Trust ...
(Date:4/20/2015)... 20, 2015 Huntington Memorial Hospital is the ... a new miniaturized, wireless monitoring sensor to manage heart ... and only FDA-approved heart failure monitoring device that has ... by physicians to manage heart failure. The ... in the pulmonary artery (PA) during a non-surgical procedure ...
(Date:4/13/2015)... , April 13, 2015 ... TechSci Research, "Global Biometrics Market Forecast & Opportunities, 2020", ... a CAGR of around 14% till 2020. The ... for large scale implementation and review of biometric ... launch of new products with greater efficiency, are ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3Global Biometrics Market to Cross US$ 21 Billion by 2020: TechSci Research 2
... breast cancer cells, according to a study published in ... just as small, or even smaller, than many blood ... healthy and sick cells, which make them interesting carriers ... In the present study, researchers from Karolinska Institutet have ...
... Nov. 7, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... Phase 1 trial of KB004, an anti-EphA3 monoclonal antibody ... the 55 th American Society of Hematology (ASH) ... KB004 is a multi-center, dose-escalation study evaluating KB004 in ...
... GLENCOE, Ill. (November 7, 2013) Chicago Botanic Garden ... grant from the National Science Foundation to study the ... need to reproduce and survive. The floral scent may ... important role in the evolution and diversification of plant ...
Cached Biology News:Nanoparticles can overcome drug resistance in breast cancer cells 2KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 2KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 3KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 4KaloBios to Present KB004 Interim Phase 1 Clinical Data in Hematologic Malignancies at ASH 5NSF awards Chicago Botanic Garden $1.54 million Dimensions in Biodiversity grant 2NSF awards Chicago Botanic Garden $1.54 million Dimensions in Biodiversity grant 3NSF awards Chicago Botanic Garden $1.54 million Dimensions in Biodiversity grant 4NSF awards Chicago Botanic Garden $1.54 million Dimensions in Biodiversity grant 5
This antibody is specific for human J-chain as defined by ELISA assay using purified human immunoglobulin fragments as solid phase target antigen....
Tissue-Stat ( Tissue Adherent for Mounting Formalin-Fixed and Frozen Tissue Sections.)...
Clarin Mounting Medium (Permanent environmentally safe mounting medium for general histology & cytology use)...
IHC Zinc Fixative - , 1000 ml Consult technical datasheet for details....
Biology Products: